Will David Sinclair be regularly taking a SGLT2 inhibitor (canagliflozin, empagliflozin) by the end of 2025?
2
140Ṁ202026
50%
chance
1D
1W
1M
ALL
This question is managed and resolved by Manifold.
Get
1,000 to start trading!
Related questions
Related questions
Will semaglutide be taken off FDA's drug shortage list in 2025?
91% chance
Will Mike Lustgarten start to regularly ANY of {rapamycin, metformin, acarbose, SGLT2 inhibitors) by the end of 2027?
58% chance
Will Morgan Levine start to regularly ANY of {rapamycin, metformin, acarbose, SGLT2 inhibitors) by the end of 2027?
54% chance
Will a drug company pay >$1m in a class action suit based on their statements about their GLP1 inhibitor by 2026?
38% chance
Will a majority government owned company introduce a new GLP-1 drug before 2040?
15% chance
Will an oral insulin pill be publicly available before the end of 2025?
24% chance
Will one of the GLP agonist drugs (eg Semaglutude/Wegovy Tirzepatide/Mounjaro) have a black box warning by 2025
7% chance
Will a GLP-1 agonist diabetes / weight loss drug be the top bestselling drug in 2025?
30% chance
Will either Lada Nuzhan or Jose Luis Ricon give in and inject semaglutide/tirzepatide at least 3 times before EOY 2025?
48% chance
Will Matt Kaeberlein start taking semaglutide/ozempic by 2030?
41% chance